Video
Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the future of microbiota modulation, with a focus on Microbial Therapeutics.
Francisco Guarner, from Centro Médico Teknon (Barcelona, Spain), talks about the recent update of the WGO’s Probiotics and prebiotics guidelines.
Bone resorption increases the risk of osteopenia and osteoporosis during and after menopause – learn about the importance of the gut microbiota to support healthy bones.
Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, talks about the mechanistic link between gut microbiome and disease pathogenesis and the impact on the future clinical practice.
Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the key determinants of success of FMT in the treatment of C. Difficile infections and other conditions.
Vegim Zhaku, from Tetovo University Faculty of Medicine, Macedonia, discussed the case of a male patient with palpitations, shortness of breath, epigastric discomfort and flatulence.
Sara Deleu, researcher at KU Leuven, talks about the role of gut metabolite, as Butyric acid and other compounds, during the fecal microbiota transplantation.
George Paraskevakos, Executive Director at International Probiotics Association, discusses the future of the microbiome space.
Iris Dothan, from Rabin Medical Center, Israel, talks about the profiling of patient with pouchitis in order to determine the benefits from microbiome manipulation.
Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.
